FamiCord AG (FRA:V3V)

Market Cap	88.03M
Revenue (ttm)	85.71M
Net Income (ttm)	-12.02M
Shares Out	n/a
EPS (ttm)	-0.68
PE Ratio	n/a
Forward PE	880.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3
Average Volume	2,214
Open	5.15
Previous Close	5.05
Day's Range	5.15 - 5.15
52-Week Range	3.70 - 5.20
Beta	n/a
RSI	60.21
Earnings Date	Aug 27, 2025

About FamiCord AG

FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the compa...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Employees: 771
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: V3V

Financial Performance

In 2024, FamiCord AG's revenue was 82.18 million, an increase of 6.65% compared to the previous year's 77.06 million. Losses were -12.14 million, 550.7% more than in 2023.